Federal Contractor Profile
The Univeristy Of Texas M.d. Anderson Cancer Center
$120M obligated·138 awards·4 agencies·20 NAICS
Federal Contracts
Showing contracts 51–100 of 166 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| May 20, 2022 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98022F00001 | 112990 | PER DIEM AND TESTING COST FOR THE NIAID OWL MONKEY COLONY | $70K |
| May 10, 2022 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $557K |
| Nov 30, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $1.0M |
| Sep 28, 2021 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40121C00180 | 541720 | IMMUNOGENICITY STUDY IN BABOONS FOLLOWING VACCINATION WITH EXPERIMENTAL ACELLULAR PERTUSSIS VACCINES. | $273K |
| Sep 27, 2021 | Department of Veterans Affairs245-NETWORK CONTRACT OFFICE 5 (36C245) | 36C24521C0180 | 541990 | MEDICAL PHYSICS PEER REVIEW OF RADIATION THERAPY QUALITY ASSURANCE OPERATIONS | $321K |
| Sep 24, 2021 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $5.2M |
| Sep 16, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00003 | 541714 | TASK ORDER TITLE: EVALUATION OF REAL-TIME METABOLIC IMAGING BIOMARKERS FOR DETECTION OF PANCREATIC PREMALIGNANT LESIONS | $1.2M |
| Sep 13, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00002 | 541714 | TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE | $933K |
| Sep 8, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98021F00002 | 112990 | PER DIEM AND TESTING OF THE NIAID OWL MONKEY COLONY (MD ANDERSON 75N98021D00018) | $90K |
| Sep 8, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98021F00001 | 112990 | SQUIRREL MONKEY, BOLIVIAN, EITHER GENDER, GREATER THAN 750 GRAM, SPF, IAW RFQ N60 (MD ANDERSON 75N98021D00018) | $32K |
| Sep 2, 2021 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40121P00534 | 112990 | MERKELOMV-AP STUDY (BABOONS) | $225K |
| Aug 30, 2021 | Department of Health and Human ServicesNIH NCI | HHSN26100007 | 541712 | IGF::OT::IGF EFFECT OF ASPIRIN ON BIOMARKERS OF BARRETT'S ESOPHAGUS AFTER SUCCESSFUL ERADICATION OF BARRETT'S ESOPHAGUS WITH RADIOFREQUENCY ABLATION | $3K |
| Jul 14, 2021 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $800K |
| Jul 13, 2021 | Department of Health and Human ServicesNIH NCI | 75N91020F00002 | 541714 | TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION | $802K |
| Jun 7, 2021 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $322K |
| May 11, 2021 | Department of Health and Human ServicesNIH NCI | 75N91021F00001 | 541714 | PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-BASED VACCINE | $636K |
| Apr 26, 2021 | Department of Health and Human ServicesNIH NCI | HHSN26100003 | 541712 | IGF::OT::IGF A PHASE IB BIOMARKER TRIAL OF NAPROXEN IN PATIENTS AT RISK FOR DNA MISMATCH REPAIR DEFICIENT COLORECTAL CANCER (MDA2013-01-02) | $40K |
| Jan 29, 2021 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018320P0543 | 813920 | RADIOLOGICAL PHYSICS CENTER QUALITY AUDIT PROGRAM | $3K |
| Jan 19, 2021 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018320P0544 | 611310 | IROC QUALITY AUDIT PROGRAM | $750 |
| Nov 30, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NLM | 75N97021C00001 | 541940 | OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | $1.0M |
| Sep 25, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00006 | 112990 | PER DIEM, AND TESTING OF THE NIAID OWL NHP COLONY | $85K |
| Sep 25, 2020 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $7.8M |
| Sep 23, 2020 | Department of Health and Human ServicesNIH NCI | 75N91018F00009 | 541711 | RANK LIGAND INHIBITION - A POTENTIAL CHEMOPREVENTION STRATEGY FOR WOMEN AT HIGH GENETIC RISK OF BREAST CANCER HHSN2612015000181 TO: HHSN26100008 PP: 9/17/18 TO 3/16/2021 | $206K |
| Sep 15, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00002 | 541714 | TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION | $389K |
| Sep 8, 2020 | Department of Health and Human ServicesNIH NCI | HHSN26100008 | 541712 | IGF::OT::IGF ALTERNATIVE DOSING OF EXEMESTANE IN POSTMENOPAUSAL WOMEN WITH STAGE 0-II ER-POSITIVE BREAST CANCER: A RANDOMIZED PRESURGICAL TRIAL | $13K |
| Sep 1, 2020 | Department of Health and Human ServicesNIH NCI | HHSN26100011 | 541712 | IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS | $96K |
| Aug 31, 2020 | Department of Health and Human ServicesNIH NCI | HHSN26100012 | 541712 | IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER | $106K |
| Aug 17, 2020 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40120P00519 | 112990 | DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY | $231K |
| Aug 4, 2020 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $566K |
| Jul 30, 2020 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40120P00459 | 112990 | BORDETELLA-FREE BABOONS | $173K |
| Jul 28, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020P00681 | 611310 | MD ANDERSON CANCER CENTER:1109568 [20-032186] DNA SAMPLES FOR A GENOME-WIDE ASSOCIATION STUDY OF LYMPHOID MALIGNANCIES | $25K |
| May 8, 2020 | Department of Health and Human ServicesNIH NCI | 75N91020F00001 | 541714 | BASE:PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY&INTERMEDIATE BIOMARKERS TASK ORDER: TARGETING STAT3 TO PREVENT HEPATOCELLULAR CARCINOMA (HCC) ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) | $843K |
| May 8, 2020 | Department of Veterans Affairs256-NETWORK CONTRACT OFFICE 16 (36C256) | 36C25620P0876 | 541690 | RATIFICATION | $590 |
| May 8, 2020 | Department of Veterans Affairs256-NETWORK CONTRACT OFFICE 16 (36C256) | 36C25620P0879 | 541690 | RATIFICATION | $590 |
| May 8, 2020 | Department of Veterans Affairs256-NETWORK CONTRACT OFFICE 16 (36C256) | 36C25620P0912 | 541690 | RATIFICATION | $900 |
| Mar 20, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00005 | 112990 | LIVE ANIMALS, NOT RAISED FOR FOOD. | $51K |
| Mar 19, 2020 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00004 | 112990 | SQUIRREL MONKEY, GUYANESE ORIGIN, ADULT, EITHER GENDER, SPFIAW WITH CONTRACT SOW AND AS NOTED IN RFP RM24 | $51K |
| Dec 18, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00002 | 112990 | PER DIEM AND TESTING TO SUPPORT THE NIAID AOTUS GRISEIMEMBRA COLONY (263201600013I) | $81K |
| Dec 18, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00003 | 112990 | SQUIRREL MONKEY (SAIMIRI BOLIVIENSIS) EITHER GENDER, GREATER THAN 700 GRAMS, SPF IAW REQUIREMENTS NOTED IN RFQ N47 (263201600013I) | $37K |
| Nov 15, 2019 | Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH OLAO | 75N98020F00001 | 112990 | OWL MONKEYS (AOTUS NANCYMAAE) GENDER MIXED, IAW RFQ N45 (263201600013I) | $153K |
| Sep 27, 2019 | Department of Health and Human ServicesHRSA HEADQUARTERS | 75R60219C00004 | 621991 | NATIONAL CORD BLOOD INVENTORY | $8.5M |
| Sep 16, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100011 | 541712 | IGF::OT::IGF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF 4-HYDROXYTAMOXIFEN TOPICAL GEL IN WOMEN WITH MAMMOGRAPHICALLY DENSE BREASTS | $692K |
| Sep 13, 2019 | Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS | 75F40119C10129 | 541714 | STUDY - MODULAR APPLICATION OF SURFACE TECHNOLOGY FOR THE GENERATION OF ANTIGEN-SPECIFIC T CELLS - BAAPMQWP#217 | $561K |
| Sep 10, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00129 | 541712 | OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH | $724K |
| Sep 10, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100009 | 541712 | IGF::OT::IGF VADIS TRIAL: PHASE II TRIAL OF E75 PEPTIDE VACCINE IN WOMEN WITH DCIS OF THE BREAST | $58K |
| Sep 10, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00131 | 541714 | REPURPOSING OF MACROLIDE ANTIBIOTIC CLARITHROMYCIN FOR THE PREVENTION OF LUNG AND BREAST CANCER | $919K |
| Sep 9, 2019 | Department of Health and Human ServicesNIH NCI | 75N91019F00132 | 541714 | CANCER PREVENTION BY VACCINATION AGAINST INDUCED ANTIGENS | $1.2M |
| Sep 7, 2019 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018319P0821 | 611310 | 06MV PHOTON | $2K |
| Aug 29, 2019 | Department of DefenseNAVAL MEDICAL CENTER PORTSMOUTH VA | N0018319P0806 | 611310 | QUALITY AUDIT PROGRAM | $600 |
| Aug 12, 2019 | Department of Health and Human ServicesNIH NCI | HHSN26100004 | 541711 | IGF::OT::IGF DETERMINATION OF DOSING REGIMENS OF ERLOTINIB IN COMBINATION WITH SULINDAC FOR PREVENTION OF COLORECTAL CANCER WHILE REDUCING AGENT TOXICITY POP 06/01/2017 - 05/31/2019 | $204K |
Get Alerted Before The Univeristy Of Texas M.d. Anderson Cancer Center's Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free